Oscar Health, Inc. current report, 16 September 2026

Oscar Health, Inc. 8-K Summary

Business Context and Reporting Period

This Form 8-K, dated September 16, 2026, announces Oscar Health, Inc.'s 2026 Investor Day. The filing serves as a Regulation FD disclosure regarding updated full-year 2026 financial guidance and strategic discussions to be presented at the event.

Key Financial Metrics and Guidance

The filing provides updated and reaffirmed full-year 2026 guidance targets:

  • Medical Loss Ratio (MLR): 81.0% to 82.0% (Improved by 50 basis points from prior guidance of 81.5% to 82.5%).
  • Earnings from Operations: $600 million to $800 million (Increased by $100 million from prior guidance of $500 million to $700 million).
  • Total Revenue: $18.7 billion to $19.0 billion (Reaffirmed).
  • SG&A Expense Ratio: 15.6% to 16.1% (Reaffirmed).

The filing does not provide historical revenue, profit, cash flow, debt, or liquidity figures for the current or prior periods; it focuses exclusively on forward-looking guidance.

Material Changes

Management has improved its outlook for operational efficiency and profitability compared to previous expectations:

  • MLR Improvement: The expected reduction in the Medical Loss Ratio indicates better-than-anticipated medical cost management.
  • Profitability Increase: The $100 million upward revision in Earnings from Operations reflects stronger expected operating leverage.

Outlook, Risks, and Unusual Items

Management will discuss long-term financial targets and strategy during the Investor Day. The filing includes standard cautionary notes regarding forward-looking statements, noting that actual results may differ materially due to risks outlined in the Company's 2025 Form 10-K. No unusual items or specific contingencies are detailed in this report.

Investor Verification Checklist

  • Verify the live webcast and presentation materials on ir.oscarhealth.com for detailed strategy discussions.
  • Review the specific drivers behind the 50 basis point improvement in the Medical Loss Ratio.
  • Confirm the assumptions underpinning the $100 million increase in Earnings from Operations guidance.
  • Monitor the 90-day archive period for the webcast following September 16, 2026.